125 related articles for article (PubMed ID: 3884747)
21. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
22. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
[TBL] [Abstract][Full Text] [Related]
23. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
[TBL] [Abstract][Full Text] [Related]
25. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
Kris MG; Gralla RJ; Clark RA; Tyson LB; O'Connell JP; Wertheim MS; Kelsen DP
J Clin Oncol; 1985 Oct; 3(10):1379-84. PubMed ID: 4045527
[TBL] [Abstract][Full Text] [Related]
26. Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
Strum SB; McDermed JE; Streng BR; McDermott NM
J Clin Oncol; 1984 Sep; 2(9):1057-63. PubMed ID: 6470755
[TBL] [Abstract][Full Text] [Related]
27. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.
Strum SB; McDermed JE; Opfell RW; Riech LP
JAMA; 1982 May; 247(19):2683-6. PubMed ID: 7043002
[TBL] [Abstract][Full Text] [Related]
28. Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting.
Colbert N; Izrael V; Lotz JP; Stoppa-Lyonnet D; Vannetzel JM; Pene F; Schlienger M; Laugier A
J Clin Oncol; 1983 Oct; 1(10):635-9. PubMed ID: 6321674
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
Dana BW; McDermott M; Everts E; Abdulhay G
Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
[TBL] [Abstract][Full Text] [Related]
30. A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.
Shiu W; Tsang V; Lam YM; Zacharia A; Martin WM
Cancer Chemother Pharmacol; 1987; 20(3):259-62. PubMed ID: 3315286
[TBL] [Abstract][Full Text] [Related]
31. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri N; Nadkarni P; Saikia TK; Gopal R; Advani SH
Cancer; 1988 Nov; 62(10):2263-6. PubMed ID: 3052785
[TBL] [Abstract][Full Text] [Related]
33. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
Saller R; Hellenbrecht D; Bühring M; Hess H
J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
[TBL] [Abstract][Full Text] [Related]
35. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
[TBL] [Abstract][Full Text] [Related]
38. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
Strum SB; McDermed JE; Liponi DF
J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
[TBL] [Abstract][Full Text] [Related]
39. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
